Last reviewed · How we verify
NCT02862392: SCOLEVOL
Predictive Progressive Factors of Adolescent Idiopathic Scoliosis
trial in Scoliosis in 95 participants. Completed in 4 December 2024.
4 December 2024
Quick facts
| Lead sponsor | Lille Catholic University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 95 |
| Start date | 15 March 2017 |
| Primary completion | 4 December 2024 |
| Estimated completion | 4 December 2024 |
| Sites | 4 locations across France |
Conditions studied
- Scoliosis — all drugs for Scoliosis →
Sponsor
Lille Catholic University
Who can join
Adults 11 to 14, female only, with Scoliosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The hypothesis of this study is that progressive AIS is characterized by a disorder of orthostatic postural control. The analysis and the treatment of posturographic signal on computerized integrate force plates, coupled to clinical and radiographic examinations, could highlight predictive and reliable factors at the moment of diagnosis. Thus, it could help the clinician in his therapeutic approach, based on the postural control improvement (individualized prescription in kinesitherapy, better adaptation to orthopedic treatments by corset). This method is non-invasive, without side effects, fast and achievable in routine care at the moment of the diagnosis of AIS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02862392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Scoliosis
Currently open trials in the same condition.
- NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
- NCT07059663 — Synergic Effects of Schroth Method With and Without Core Stabilization Exercises in Idiopathic Scoliosis Patients · NA · recruiting
- NCT06540885 — A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery · Phase 4 · recruiting
- NCT06242821 — Yoga for Back Pain in Adolescent Scoliosis · NA · recruiting
- NCT06451562 — Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery · NA · recruiting
Other Lille Catholic University trials
Trials by the same sponsor.
- NCT06634225 — Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP) · completed
- NCT06116929 — Hodgkin's Disease and Chemotherapy Before 40 Years · NA · not yet recruiting
- NCT05208099 — Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy · not yet recruiting
- NCT06318923 — Social and Moral Cognition in Multiple Sclerosis · NA · unknown
- NCT06083415 — Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02862392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lille Catholic University
- Last refreshed: 10 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02862392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing